Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „empagliflozin“
Suchtreffer
Begriffe & Kennungen
Glyxambi · 4.5 · Co-administration of empagliflozin with probenecid, an inhibitor of UGT enzymes and OAT3, resulted in a 26% in
Eintrag öffnenGlyxambi · 4.5 · Effects of empagliflozin on other medicinal products
Eintrag öffnenGlyxambi · 4.5 · Effects of other medicinal products on empagliflozin
Eintrag öffnenGlyxambi · 4.5 · Empagliflozin is mainly excreted unchanged. A minor fraction is metabolised via uridine 5'-diphosphoglucuronos
Eintrag öffnenGlyxambi · 4.5 · Empagliflozin may add to the diuretic effect of thiazide and loop diuretics and may increase the risk of dehyd
Eintrag öffnenGlyxambi · 4.5 · Empagliflozin may increase renal lithium excretion and the blood lithium levels may be decreased. Serum concen
Eintrag öffnenGlyxambi · 4.5 · Interaction studies conducted in healthy volunteers suggest that empagliflozin had no clinically relevant effe
Eintrag öffnenGlyxambi · 4.5 · Interaction studies suggest that the pharmacokinetics of empagliflozin were not influenced by co- administrati
Eintrag öffnenGlyxambi · 4.8 · 11 comparable to those reported from the empagliflozin clinical trials (see also section 4.4).
Eintrag öffnenGlyxambi · 4.8 · 12 25 mg/5 mg: 0.4%; Glyxambi 10 mg/5 mg: 0.6%) has been comparable to those reported from the empagliflozin c
Eintrag öffnenGlyxambi · 4.8 · Based on the experience with empagliflozin and linagliptin, an increase of the risk of hypoglycaemia is expect
Eintrag öffnenGlyxambi · 4.8 · Hypoglycaemia with empagliflozin The frequency of hypoglycaemia depended on the background therapy in the resp
Eintrag öffnenGlyxambi · 4.8 · In clinical trials with empagliflozin, increased urination (including the predefined terms pollakiuria, polyur
Eintrag öffnenGlyxambi · 4.8 · In clinical trials with empagliflozin, the overall frequency of patients with increased blood creatinine and d
Eintrag öffnenGlyxambi · 4.8 · In clinical trials with empagliflozin, the overall frequency of volume depletion (including the predefined ter
Eintrag öffnenGlyxambi · 4.8 · In empagliflozin trials, the overall frequency of urinary tract infection was similar in patients treated with
Eintrag öffnenGlyxambi · 4.8 · In empagliflozin trials, vaginal moniliasis, vulvovaginitis, balanitis and other genital infections were repor
Eintrag öffnenGlyxambi · 4.8 · Major hypoglycaemia with empagliflozin (events requiring assistance) The frequency of patients with major hypo
Eintrag öffnenGlyxambi · 4.8 · The frequency of patients with major hypoglycaemic events was increased in patients treated with empagliflozin
Eintrag öffnenGlyxambi · 4.8 · The most frequent adverse reaction was urinary tract infection (7.5% with Glyxambi 10 mg empagliflozin/5 mg li
Eintrag öffnen